Vanderbilt-Ingram Cancer Center Archive — Page 17 of 27
-
February 10, 2022
Pietenpol named chief scientific and strategy officer
Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center (VICC), Benjamin F. Byrd Jr. Professor of Oncology and Executive Vice President for Research for Vanderbilt University Medical Center, is stepping down on June 30 from her long-held role as the Cancer Center’s director to focus on a combined leadership role for VUMC as chief scientific and strategy officer (CSSO). -
February 3, 2022
Osterman plays key role in major oncology EHR initiative
Vanderbilt's Travis Osterman, DO, MS, is leading an integral component of the Minimal Common Data Elements (mCODE) initiative, establishing common data standards for oncology clinicians and researchers. -
January 27, 2022
New fund supports appendiceal cancer research
-
January 25, 2022
Comprehensive framework outlined for addressing early-onset colorectal cancer research
New research from Vanderbilt sets a comprehensive framework for addressing research challenges and patient needs for people under 50 with colorectal cancer. -
January 24, 2022
Donna Atherton and Karen Pinkard are nurses who have worked together for years. The day Karen’s heart stopped at work, Donna was there to save her life.
A lot of people worked to save her life and help her recover. Thanks to them, Karen Pinkard is back at work. -
January 19, 2022
Clinical score can guide PRRT therapy decisions for neuroendocrine tumors
A clinical score system developed by researchers at Vanderbilt-Ingram Cancer Center (VICC) has been validated that can guide peptide receptor radionuclide therapy treatment decisions. -
January 5, 2022
Drug modifies epigenome in aggressive brain tumors: study
A folic acid-like drug changed a DNA process within brain tumors of glioblastoma patients, according to results from a phase 1 clinical trial.